NCT03500783View on ClinicalTrials.gov

Nitric Oxide-mediated Cardioprotection During Cardiac Surgery With Cardiopulmonary Bypass

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 15, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Coronary Artery DiseaseCoronary Artery BypassCardiopulmonary BypassNitric OxideReperfusion Injury, Myocardial
Interventions
DRUG

Nitric Oxide

40 ppm of exogenous gaseous nitric oxide is supplied directly to the oxygenator in the cardiopulmonary bypass circuit during coronary artery bypass grafting.

OTHER

Standard CPB

Standard protocol of delivery of air gas mixture to the cardiopulmonary bypass circuit

All Listed Sponsors
lead

Tomsk National Research Medical Center of the Russian Academy of Sciences

OTHER

NCT03500783 - Nitric Oxide-mediated Cardioprotection During Cardiac Surgery With Cardiopulmonary Bypass | Biotech Hunter | Biotech Hunter